Search Results

FAQ COS'È MOLNUIRAVIR? Molnupiravir (MK-4482, EIDD-2801) è una forma sperimentale, somministrata per via orale di un potente analogo del ribonucleoside che inibisce la replicazione di SARS-CoV-2, l'agente eziologico di COVID-19. Molnupiravir è allo studio come medicinale singolo, senza l'uso di medicinali concomitanti e senza restrizioni sull'assunzione di cibo o modifiche della dose basate su insufficienza renale o epatica. Sulla base dei dati disponibili, non sono state identificate interazioni farmacologiche note con molnupiravir. CHE COS'È MOLNUPIRAVIR GENERIC DRUG? Merck ha concesso una licenza esente da royalty per la sua promettente pillola Covid-19 a un'organizzazione no profit sostenuta dalle Nazioni Unite in un accordo che consentirebbe la produzione e la vendita del farmaco a basso costo nelle nazioni più povere, dove i vaccini per il coronavirus sono in tempi devastanti la fornitura. L'accordo con il Medicines Patent Pool, un'organizzazione che lavora per rendere le cure mediche e le tecnologie accessibili a livello globale, consentirà alle aziende di 105 paesi, principalmente in Africa e in Asia, di concedere in sublicenza la formulazione per la pillola antivirale , chiamato molnupiravir e inizia a realizzarlo. QUAL È LA DIFFERENZA TRA LA VERSIONE MERCK E LA GENERICA? Non c'è differenza di qualità tra la versione Merck e i Generics prodotti da impianti di produzione generici indiani. Sono stati approvati dal pool di brevetti di medicinali per ricevere la formula Merck esatta da utilizzare e le materie prime sono state testate per garantire la qualità per assicurarsi che soddisfi tutti gli standard Merck. PERCHE' PILLOLE? Gli altri prodotti covid-19 sul mercato sono stati farmaci per iniezione o per via endovenosa. Questi hanno sfide per quanto riguarda la conservazione, il trasporto e la somministrazione dei farmaci. Avere una forma di pillola rende molto più facile raggiungere una grande quantità di persone in un breve lasso di tempo oltre ad essere molto conveniente. CI SONO ALTRE PILLOLE ANTIVIRALI SUL MERCATO? Sì, anche la Pfizer è uscita con una pillola antivirale chiamata paxlovid. Non sarà disponibile per la spedizione almeno fino a metà febbraio e avremo accesso anche quando sarà disponibile. PUOI COMBINARE ENTRAMBE LE PILLOLE ANTIVIRALI? Sì, le pillole prendono di mira diversi picchi proteici, quindi i medici hanno affermato che potrebbe essere utile assumere un cocktail antivirale di entrambe le formule Merck e Pfizer. QUAL È IL DOSAGGIO DI MOLNUPIRAVIR ? 4 pillole da 200 mg due volte al giorno per 5 giorni. C'E' QUALCUNO CHE NON DEVE PRENDERE MOLNUPIRAVIR ? Chiunque abbia meno di 18 anni o stia pensando di rimanere incinta durante l'utilizzo di molnupiravir. QUANTO EFFICACE IL FARMACO? A rischio di ricovero da moderato ad alto, molnupiravir ha dimostrato di essere efficace del 30-50% nel tenere i pazienti fuori dall'ospedale a seconda del gruppo a cui appartengono i pazienti. CHI È MPP Il Medicines Patent Pool (MPP) è un'organizzazione per la salute pubblica sostenuta dalle Nazioni Unite che lavora per aumentare l'accesso e facilitare lo sviluppo di medicinali salvavita per persone a basso rischio e paesi a reddito medio. COS'È CHI GMP Le buone pratiche di fabbricazione (GMP, denominate anche 'cGMP' o 'attuale buona pratica di fabbricazione') sono l'aspetto della garanzia di qualità che garantisce che i medicinali siano prodotti e controllati in modo coerente secondo gli standard di qualità appropriati all'uso previsto e come richiesto da la specifica del prodotto. ​ GMP definisce le misure di qualità sia per la produzione che per il controllo di qualità e definisce le misure generali per garantire che i processi necessari per la produzione e i test siano chiaramente definiti, convalidati, rivisti e documentati e che il personale, i locali e i materiali siano idonei per la produzione di prodotti farmaceutici e biologici compresi i vaccini. GMP ha anche componenti legali, che coprono le responsabilità di distribuzione, produzione a contratto e test e risposte a difetti e reclami del prodotto. I requisiti GMP specifici relativi a classi di prodotti come i prodotti farmaceutici sterili oi medicinali biologici sono forniti in una serie di allegati ai requisiti GMP generali. ESISTONO ISTRUZIONI SPECIALI PER LA GESTIONE? No Molnupiravir è uno dei farmaci covid-19 più facili da trasportare e somministrare sul mercato DOVE PUO' ESSERE SPEDITO MOLNUPIRAVIR? Ci sono solo una manciata di paesi in cui il farmaco non può essere venduto. Quasi tutti i paesi possono essere accettati con un permesso speciale.

GCAP SALUTE INTELLIGENTE BIOSIMILAR DRUG PLATFORM Qualità, convenienza, Efficienza • Alta qualità and simile a innovator Molecule. • Marchio commerciale e di marca. • Strong Medical Regulatory process in linea con il consiglio internazionale di armonizzazione (ICH) • Blockchain Integrated Logistica e gestione della catena di approvvigionamento. Protocolli di scadenza dei farmaci basati su NFT. • Rete di distribuzione globale diretta ai governi e ai distributori esistenti. • Solo il marchio Global Generic che copre farmaci vecchi e nuovi. PERSONAL GESTIONE BENESSERE Personale, Precisione, Cura Prodotti naturali per la salute Recupero post COVID Nanotecnologia Guarigione Quantistica SUPPORTO PER L'INCUBAZIONE BIOTECH Avanzato, alternativo Tecnologia di diagnosi avanzata Diagnosi a distanza Imaging medico Nanotecnologia Supporto al percorso clinico Health: Programs

Guarda ora Facebook Twitter Pinterest Tumblr Copia il Link Link copiato

GCAP HTP GCAP Humanitarian Trading Platform (HTP) è una piattaforma riservata ai membri che consente ai membri GCAP di partecipare al commercio globale di materie prime in modo efficiente, con percentuali di successo significativamente più elevate. HTP sostiene l'impegno di GCAP per le opere umanitarie globali. In qualità di proprietario e operatore di GCAP HTP, GCAP utilizza il 20% dei suoi guadagni da HTP per iniziative umanitarie globali. HTP sarà sviluppato come un sistema avanzato che coinvolge le ultime tecnologie IT, come Blockchain, criptovalute e altre. ENERGIA Gasolio Carburante per jet GNL Bitume METALLO E MINERALE Lingotti di alluminio catodo di rame Minerale di ferro AGRICOLO Soia (non OGM) Mais cotone Olio di colza/olio di girasole Zucchero bianco PRODOTTO DI CARNE Frutti di mare Manzo Maiale Pollo Contattaci oggi e inizia a essere coinvolto.

INIZIATIVE GCAP Dalla salute intelligente alla sostenibilità globale INIZIATIVA GCAP PER LA SALUTE INTELLIGENTE Soluzioni sanitarie intelligenti basate su tecnologie indossabili avanzate, diagnosi rapida, big data sanitari e nanotecnologie INIZIATIVA DI SOSTENIBILITÀ GCAP Energia a idrogeno / Generatore di idrogeno / Stoccaggio di idrogeno allo stato solido Gestione ambientale/dei rifiuti PROGRAMMA GIVE-BACK GCAP GCAP acquista energia e minerali, allo stesso tempo, GCAP restituisce alla comunità PIATTAFORMA COMMERCIALE UMANITARIA GCAP Programma di riacquisto garantito di cibo e agricoltura Commodity Trading supportato da Blockchain, NFT GCAP FONDO UMANITARIO Sanità e nutrizione Gestione ambientale Sviluppo delle infrastrutture Alloggi economici Soccorso in caso di calamità Interessato a unirti alla nostra causa?

GCAP's Humanitarian Effort to Address the Refugee Crisis at the Border Collaboration, Empowerment, and Hope for a Better Future Introduction ​ At GCAP Group, we are proud to announce our dedicated humanitarian effort aimed at addressing the pressing refugee crisis at the border. With a vision to foster positive change and improve the lives of those in need, we have taken the lead in developing a transformative initiative that combines collaboration, empowerment, and hope for a better future. Refugee Crisis The refugee crisis at the border demands immediate attention and comprehensive solutions. We recognize the urgency and complexity of the situation, and GCAP Group is committed to making a lasting impact through a multifaceted approach. Benefits Our initiative offers numerous benefits to address this humanitarian challenge effectively: ​ Structured Support and Integration: By constructing and operating Refuge Integration Hubs, we provide a structured and supportive environment for refugees, ensuring their integration into society. Reduced Pressure on Border Control: Through our initiative, we aim to mitigate irregular border crossings, alleviating the strain on U.S. border control agencies and resources. Humanitarian Relief and Empowerment: We address the root causes of migration and strive to alleviate the humanitarian challenges associated with the refugee crisis at the border, promoting empowerment and resilience. Decreased Asylum Applications: Our long-term integration and empowerment strategies contribute to reducing the number of asylum applications, relieving the burden on the U.S. immigration system. Regional Stability and Economic Growth: Through vocational training programs, we foster social and economic development in Mexico, creating opportunities for increased business collaborations with esteemed U.S. companies. Business and Investment Community Proposal In addition to our existing efforts, we propose further collaboration with the business and investment community to address Central American refugee issues with economic, educational and humanitarian solutions. By leveraging our collective resources and expertise, we can create sustainable opportunities for refugees to rebuild their lives through education, job training, and economic empowerment. Public Private Partnership To ensure the success of this initiative, GCAP Group is proud to pledge our partnership with various private partners, including charity groups, non-profit organizations, esteemed institutions and members of the business and investment community. Through a Public-Private Partnership (PPP), we aim to combine our resources, expertise, and passion to bring about positive change on a significant scale. Call To Action ​ GCAP Group is steadfast in our resolve to lead this humanitarian effort driven by our unwavering commitment to compassion collaboration and empowerment. We believe that by working together with all stakeholders involved including members of the business community we can create sustainable solutions and foster positive change for refugees and communities involved. Let us stand united in building a better world for all. Your support and involvement can make a profound difference in the lives of those affected by the refugee crisis at the border. Together we can create a brighter future. Donate/Get Involved Submit Thanks for submitting!

PROGRAMMA DI DONAZIONE MOLNUPIRAVIR (MDP) SU MDP GCAP sta lavorando insieme ai produttori indiani di farmaci generici, alle Nazioni Unite e alle sue organizzazioni affiliate, alle fondazioni di beneficenza in tutto il mondo, per consegnare milioni di farmaci generici Molnupiravir nelle mani di coloro che ne hanno bisogno nei paesi in via di sviluppo. CENTRO INFORMATIVO INFOGRAFICHE MDP Informazioni sul programma MDP, statistiche COVID-19, notizie about Molnupiravir Scarica Riproduci Video Riproduci Video 01:30 9 News Australia Molnupiravir annoucement Molnupiravir is described as a promising new weapon to tackle COVID-19 ... SCHEDA MOLNUPIRAVIR Disponibile per il download GCAP MOLNUPIRAVIR I membri dell'alleanza del Gruppo GCAP lavorano insieme per promuovere il benessere dell'umanità in tutto il mondo ... Scarica LINEE GUIDA PER LA QUALITÀ GCAP MOLNUPIRAVIR I membri dell'alleanza del Gruppo GCAP lavorano insieme per promuovere il benessere dell'umanità in tutto il mondo ... Scarica

LABORATORI DI PROVA GCAP GCAP Global lavora fianco a fianco con i migliori team nel campo dei test sui virus COVID-19, Lab Equipment and medical produttori e fornitori di materiali di consumo,_cc781905- 5cde-3194-bb3b-136bad5cf58d_Global Logistic Service, per offrire le soluzioni di laboratorio di prova più avanzate e integrate a livello mondiale. _cc781905-4-bb-319 136bad5cf58d_ Per affrontare le sfide che il tuo Paese sta affrontando per combattere COVID-SARS-2 o altre malattie infettive, contatta GCAP Global oggi.

GCAP Energy Relief Humanitarian Program Most of the world's economies face a growing energy crisis due to global supply disruptions, high energy prices, geopolitical instability and an unrealized energy transition from carbon-intensive sources. The energy shortage has driven up energy prices for many consumers and businesses around the world, hurting households, industries and entire economies - most in developing countries where people can't afford them. We, GCAP Group is working together with our global alliance partners in oil and gas supply, trade finance and logistics to develop GCAP Energy Relief Humanitarian Program (ERHP) for developing countries facing energy shortages. Under ERHP, the participating GCAP alliance partners will collaborate together and address various challenges including high energy cost, shortage of vessels, and financial capital needs. Like the commodity trading program under GCAP Humanitarian Trading Platform, a portion of the proceedings of this program will be given back to the local community to improve the infrastructure. GCAP alliance partners will also seek to help bring alternative energy to the needed nations. The current alliance partners including Nigeria National Petroleum Corp, PT Pertamina, China Northern Oil, Canaf Refinery, Santa Oil, Eagle Capital and CGI Mineral Fund. GCAP Group invites its 400+ global alliance partners joint force to assist the needed nations, such as Sri Lanka and others. For details about how to participate in Energy Relief program, please contact us energyrelief@gcapglobal.org About GCAP GCAP is an innovative social enterprise formed by trusted partners including top bankers, global financiers, infrastructure funds, pension funds, fund of funds, sovereign wealth funds, charity and humanitarian funds. GCAP’s core mission is to advance new frontiers of science, tech innovation and policy making to solve global challenges related to Global Supply Chain, Healthcare, Climate Change and Social Equalities. GCAP consists of more than 400 members in over 40 countries. Our members are influential in many sectors including logistics, financial, governmental, manufacturing, banking, insurance, government agencies, and industries. About China Northern Oil North Petrochemical (Group) Co., Ltd. was established in 1997 and is headquartered in Xi'an, Shaanxi. It is a comprehensive energy company integrating domestic and foreign oil and gas exploration and development, oil product trade, warehousing and logistics, investment, construction and operation. North Petroleum adheres to the management policy of relying on resources, the market as the link, and the technology as the guide, closely following the national "One Belt, One Road" strategic policy, realizing the interconnection of domestic and foreign energy storage and logistics, and realizing the service of the whole oil industry chain, in order to protect the country's energy Contribute to the scientific development of security and the national economy. ​ About Canaf Refinery Canaf is a global consortium group of energy and petrochemical companies that aims to meet the world’s growing need for more and cleaner energy solutions in ways that are economically, environmentally, and socially responsible. Our operations are divided into our businesses: Midstream, Integrated Gas and Canaf's Energy Solutions (formerly New Energies), and Downstream. Our Projects & Technology organization manages the delivery of Canaf’s major projects and drives our research and innovation. Our Midstream sector organization manages, namely in acquisition, transportation, storage, and wholesale marketing of crude oil, low pour fuel oil, natural gas, and natural gas liquids (butane and propane). It also markets and transports oil and gas and operates the infrastructure necessary to deliver them to market. Our Integrated Low Pour Fuel Oil organisation manages our feedstock activities and the production of LPFO the main reason for this is since LPFO is one of the products in the fractional distillation of crude oil refining . Fuel oil is used as bunker fuel , or fuel to run boilers / furnaces, heating in many industries especially textile and cement manufacturing industries. Also used to run fuel oil / crude oil generators of heat or used in an engine for the generation of power, except oils having a flash point of approximately 40 °C (104 °F). It also markets and transports LPFO and operates the infrastructure necessary to deliver it to market. Our Integrated Gas organization manages our liquefied natural gas (LNG) activities and the production of gas-to-liquids (GTL) fuels and other products. It includes natural gas, and the operation of the upstream and midstream infrastructure necessary to deliver gas to market. It markets and trades natural gas, LNG, LPG, BLCO, LPFO , crude oils, electricity, carbon-emission rights and also markets and sells LNG as a fuel for heavy-duty vehicles and marine vessels. Renewables and Energy Solutions is the part of Canaf focused on finding commercial ways to meet the evolving energy needs of our customers. These solutions include power from renewable and low-carbon sources such as wind, solar and natural gas and decarbonization options including nature-based solutions and carbon capture and storage. This part of Canaf also develops new business models such as clean power-as-a-service, which addresses how digital technology can better help customers with their energy needs. Our Downstream organization serves millions of customers at retail sites every day. It manages different Chemicals and Products activities as part of an integrated value chain that trades and refines BLCO and other feedstocks into a range of products which are moved and marketed around the world for domestic, industrial and transport use. The products we offer customers include conventional fuels for road (Gasoline / Petrol - Regular 87, Mid-Grade 89, Premium 92 , Diesel D2 ), aviation (Kerosene - Jet Fuel: Jet A & Jet A1, AVGAS: 100 & 100LL, Aviation Fuel: TS-1, Jet B, JP-8, JP-5 ) and shipping (Marine Fuel Oil CST 380 – LPFO ); low-carbon fuels such as biofuels, renewable natural gas (RNG) , hydrogen and electric-vehicle charging. We also produce and sell LNG, LPG and petrochemicals worldwide. Our Projects & Technology organization manages the delivery of our major projects and drives research and innovation to develop new technology solutions. It provides technical services and technology capability for our Integrated Gas, Upstream and Downstream activities. It is also responsible for providing functional leadership across Canaf in the areas of safety and environment, contracting and procurement, pipeline activities and greenhouse gas management. About Santa Oil Santa Oil LLC is a Delaware registered company with offices in Washington DC and Beijing that focuses on providing stable fuel delivery to service the fast-growing energy demand in China and Asia. Our team has decades of experience working in the US, China, Asia and other parts of the world. About PT Pertamina PT Pertamina (Persero) has now journeyed with over six decades of experience in the energy industry. Pertamina continues to work hard in building the nation through strengthening its commitment in the fields of New and Renewable Energy and Business Diversification. This commitment is demonstrated through the provision of more quality products to meet the demands of consumers for superior products. It is now time for Pertamina to strengthen its steps, in order to face a variety of challenges with optimism so as to create sustainable business growth for the Company through investment and business optimization in order to continue growth in line with the expectations of all stakeholders. The Milestones of Pertamina has started in the 1950s, the Government of the Republic of Indonesia appointed the Army, which later established PT Eksploitasi Tambang Minyak Sumatera Utara to manage oil fields in the Sumatra region. On 10th December 1957, the Company then changed its name to PT Perusahaan Minyak Nasional, abbreviated to PERMINA. This date is celebrated as the birth of Pertamina to this day. In 1960, PT Permina changed its status to a State Enterprise (PN) Permina. Later, PN Permina joined PN Pertamin to become PN State Oil and Natural Gas Mining Company on 20th August 1968. Afterward, the government regulated the role of Pertamina so as to produce and process oil and gas from oil fields as well to provide for the fuel and gas demands in Indonesia through Law No.8 of 1971. Furthermore, through Law No.22 of 2001, the government changed the position of Pertamina, allowing the implementation of Public Service Obligation (PSO) to be conducted through the business activities. Based on Government Regulation No.31 of 2003 dated 18th June 2003, the State Oil and Natural Gas Mining Company changed its name to PT Pertamina (Persero) which engaged in oil and gas business activities from the Upstream Sector to the Downstream Sector. PT Pertamina (Persero) was established on 17th September 2003 based on Notarial Deed No.20 of 2003. On 10th December 2005, Pertamina transformed the seahorse logo into arrows with green, blue, and red base colors that reflect the dynamic elements and environmental awareness. Through a subsidiary, PT Pertamina International EP, Pertamina became the majority shareholder of Maurel et Prom (M&P) with 72.65% of shares. PT Pertamina (Persero) transformed the Company’s business and fundamentals on 20th July 2006. PT Pertamina (Persero) changed the Company’s vision to “Becoming a World-Class National Oil Company” on 10th December 2007. In 2011, Pertamina improved its vision to “Becoming a World-Class National Energy Company”. Through the EGM dated 19th July 2012, Pertamina increased its issued/paid-up capital as well as expanded its business activities. On 14th December 2015, the Minister of SOE at the General Meeting of Shareholders approved the amendment to the Articles of Association of Pertamina in optimizing the utilization of resources, increasing on the issued and subscribed capital by the state as well as the Board of Directors’ actions that require written approval from the Board of Commissioners. This amendment has been stated in Deed No.10 dated 11th January 2016, Notary Lenny Janis Ishak, SH. In 2017, one of the real steps to realize the vision of becoming a world-class national energy company was to successfully complete the acquisition of French oil and gas company Maurel et Prom (M&P). Effective from 1st February 2017 through a subsidiary, PT Pertamina International EP, Pertamina became the majority shareholder of M&P with 72.65% of shares. Through its majority shareholding in M&P, Pertamina has access to operations in 12 countries spread over 4 continents. In the future, Pertamina aims to produce 650 thousand BOEPD (Barrels of Oil Equivalents Per Day) by 2025 from its international operations, as part of Pertamina’s production target of 1.9 million BOEPD by 2025, in a determined effort towards establishing Indonesia’s energy resiliency and self-sufficiency. ​ About CGI Mineral Fund CGI invests in the companies with leading positions, proven performance, and committed teams. CGI delivers values to the businesses by leveraging its expertise, full resources of network, strategic insights, and capital support. The Management and Board of Directors of Cynergy Global Investment Company Pte. Ltd. has vast experience in the financial sector as well as the international trade sector handling various commodities. Mr Li Jun Lun, Mr Saravanan & Mr Sheik are part of the main board of directors and carry with them over 20 years of multilateral experience. Supplying of Crude oil and various other Oil & Gas commodities, poultry and other meat products as well as various soS commodities such as coffee, soy and sugar. In the course of supporting the multilateral trade within Asia, Cynergy Global Investment Pte Ltd was set up. To not only support, but also to finance supply chains as well as strategically invest in developing regions within China and other Asian nations. ​

FARMACO GENERICO GCAP PER COVID-19 Molnupiravir (Lagevrio) è la prima terapia antivirale orale sperimentale per il trattamento di SARS-CoV-2 (COVID-19) in pazienti adulti non ospedalizzati. È un potente analogo del ribonucleoside che blocca la replicazione di SARS-CoV-2 agendo come substrato competitivo della RNA polimerasi RNA-dipendente codificata viralmente. INFORMAZIONI SULLA FARMACIA Molnupiravir ​ Prossimamente INFORMAZIONI DI FABBRICA PROSSIMAMENTE INCHIESTA Inizia ora Nome di battesimo Cognome E-mail Telefono Azienda Posizione Invia Grazie per l'invio!

GCAP+EPRO GCAP Global has signed strategicpartnership with ePRO_cc781905- 5cde-3194-bb3b-136bad5cf58d_&CAPUP to builda global trading platform to_cc781905-5cde -3194-bb3b-136bad5cf58d_meet thechallenges in global supply chaindisrupted_cc781905-5cde-3194-bb3b-136bad5c-136bad5c-136bad5b-136bad5b-136bad5b-136bad5 The collaboration combines GCAP'sstrengths in Global_cc781905-5cde-3194-bb3b- 136bad5cf58d_Trading and Capitalmarket, and ePRO's global logisticnetwork across over_cc781905-5cde-3194 -bb3b-136bad5cf58d_40 countries.

PFIZER/BIONTECH (BNT162B2) Di più MODERNA (MRNA-1273) Di più JOHNSON & JOHNSON (AD26.COV2.S) Di più OXFORD/ASTRAZENECA (AZD1222) Di più SINOPHARMA (PECHINO) BBIBP-CORV (CELLULE VERO) Di più